Edward Nash Stock Analyst Profile - Canaccord Genuity Research Coverage - Stocknear

Edward Nash

Stock Analyst at Canaccord Genuity

(3.7)
# 2207
Out of 5,493 analysts
115
Total ratings
Success rate
Average return

31 Stocks

Name Action PT Current % Upside Ratings Updated
CORT Corcept Therapeutics
Maintains: Buy
140 140
83.87 66.93% 10 Sep 25, 2025
CLDX Celldex Therapeutics
Maintains: Buy
62 62
26.14 137.18% 3 Sep 17, 2025
MDGL Madrigal Pharmaceuti...
Maintains: Strong Buy
428 526
424.23 23.99% 11 Sep 12, 2025
SGMT Sagimet Biosciences
Initiates Coverage On: Buy
28
7.34 281.47% 1 Jul 24, 2025
VRNA Verona Pharma
Downgrades: Hold
107
106.69 0.29% 10 Jul 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
45 47
25.3 85.77% 10 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
n/a n/a 2 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4
1.52 163.16% 2 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
56 73
47.74 52.91% 6 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
89
38.22 132.86% 1 Nov 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 14
2.98 369.8% 6 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 8
1.08 640.74% 3 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 20
6.05 230.58% 2 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
68 66
n/a n/a 2 Mar 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
20 19
n/a n/a 9 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Hold
8
3.39 135.99% 4 Jul 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
71 48
n/a n/a 3 Jun 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
16 17
9.34 82.01% 2 May 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3 2
2.41 -17.01% 4 May 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
19 17
n/a n/a 2 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
900 180
1.39 12849.64% 2 Aug 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
52
n/a n/a 2 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
n/a n/a 1 Apr 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
19 1
n/a n/a 2 Oct 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 82
29.08 181.98% 5 Jun 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
120 80
4.51 1673.84% 3 Sep 13, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
10 3
n/a n/a 1 Nov 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 Oct 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
48
54.31 -11.62% 1 May 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
650
5.44 11848.53% 1 Nov 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
150 0
n/a n/a 3 Sep 22, 2017